Q3 2018 AstraZeneca PLC Earnings Call

8/11/2018 7:00

Conference Call AstraZeneca PLC

AstraZeneca PLC Conference call or earnings call will be held on 08-Nov-2018 via an 800 number (toll-free). During the earnings conference call's session AstraZeneca PLC will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact AstraZeneca PLC for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in various therapy areas, including respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology, as well as in infection, neuroscience and gastrointestinal areas. The Company has its operations in over 100 countries. The Company's pipeline includes over 150 projects of which approximately 125 are in the clinical phase of development. The Company is developing a Toll-like receptor 9 (TLR-9) receptor agonist aimed at producing long-term benefit in asthma by addressing imbalances in the immune system. AstraZeneca offers various products, including Accolate, Rhinocort, Bricanyl Turbuhaler, Rhinocort, Symbicort pMDI, Crestor, Seloken/Toprol-XL, Brilinta/Brilique (ticagrelor), Bydureon, Xigduo XR, Kombiglyze XR and metformin XR, among others.
Read more Conference Call

AstraZeneca PLC (AZN.L)

AstraZeneca PLC - Legal Department, 2 Kingdom St LONDON     W2 6BD P: +4420.73045000 F: +4420.76048151